ZB Sports Club was filled with the sound of pounding feet and determined breaths as runners of all ages and abilities participated at the Harare edition of CIMAS iGo Half Marathon on Sunday.
The event, which included 21km, 10km, and 5km races, drew over 1500 runners and served as a powerful platform to raise awareness for men’s health issues, particularly prostate cancer.
In the 21km race, Edson Nyadembera emerged as the clear winner, finishing with an impressive time of 01:17:56, over two minutes ahead of the second-place finisher, Davison Madzivanyika (01:19:47).
The 10km race saw Watson Masendeke take the top spot with a time of 00:40:53, just two seconds ahead of Samuel Vutete (00:40:55). Mthokozisi Ncube won the 5km race in 00:24:01, followed closely by Tichaona Mupazviripo in 00:25:19.
Tatenda Madzikanda, Chief Marketing Officer of CIMAS Health Group, shared her excitement about the event’s success.
“We are happy it has been a success, with over 1500 runners coming through to participate,” Madzikanda said. “We trust and believe that we’ve played our roles in raising awareness about men’s health issues, and in particular, prostate cancer.”
Madzikanda also announced that the CIMAS iGo half marathon event will take place in Bulawayo on Sunday, inviting everyone to join the cause.
The Cancer Association of Zimbabwe (CAZ) was a major beneficiary of the event, with funds raised going towards patient support, including the purchase of chemotherapy drugs for cancer patients and food hampers to ensure positive treatment outcomes. CAZ General Manager Junior Mavu expressed her gratitude to CIMAS for their support.
“We want to thank CIMAS for supporting the Cancer Association because, without them, we will not be able to offer the services that we do to cancer patients, their caregivers, and their families,” Mavu said.
Through the combined efforts of CIMAS, CAZ, and the inspiring runners who participated, the CIMAS Marathon successfully raised awareness for prostate cancer and other men’s health issues while making a tangible difference in the lives of those affected by cancer.
